Cargando…

Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10‐Year Cohort

BACKGROUND: Heart failure is a highly prevalent cardiovascular complication among patients receiving long‐term hemodialysis, but the benefits of carvedilol, bisoprolol, and metoprolol controlled release/extended release on the outcomes of these patients remain unclear. In this study, we address the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Chao‐Hsiun, Wang, Chia‐Chen, Chen, Tso‐Hsiao, Hong, Chuang‐Ye, Sue, Yuh‐Mou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859376/ https://www.ncbi.nlm.nih.gov/pubmed/26738790 http://dx.doi.org/10.1161/JAHA.115.002584

Ejemplares similares

Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease
por: Su, Vincent Yi-Fong, et al.
Publicado: (2016)

Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease: Erratum
Publicado: (2016)

Differential Effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on Cardiac K(v)4.3 (I(to)) Channel Isoforms
por: Rahm, Ann-Kathrin, et al.
Publicado: (2023)

Comparative effectiveness of bisoprolol and carvedilol among patients receiving maintenance hemodialysis
por: Wu, Ping-Hsun, et al.
Publicado: (2021)

Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate
por: Vaidya, Varun, et al.
Publicado: (2012)

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
por: Choi, Ki Hong, et al.
Publicado: (2019)

Metoprolol succinate extended release/hydrochlorothiazide combination tablets
por: Hainer, James W, et al.
Publicado: (2007)

Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
por: Barold, S. Serge, et al.
Publicado: (2018)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Effect of adrenergic blockers, carvedilol, prazosin, metoprolol and combination of prazosin and metoprolol on paracetamol-induced hepatotoxicity in rabbits
por: Zubairi, Maysaa B., et al.
Publicado: (2014)

In Silico Comparison Between Metoprolol Succinate and Bisoprolol on 24-Hour Systolic Blood Pressures
por: Jansson, Sven-Olof, et al.
Publicado: (2014)

Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling
por: Issa, Michele Georges, et al.
Publicado: (2022)

Design and characterization of controlled release tablet of metoprolol
por: Singhvi, Gautam, et al.
Publicado: (2012)

Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes
por: Bussey, Carol T., et al.
Publicado: (2020)

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
por: Düngen, Hans-Dirk, et al.
Publicado: (2011)

Design and in vitro evaluation of a novel controlled onset extended-release delivery system of metoprolol tartrate
por: Emami, Jaber, et al.
Publicado: (2016)

Effects of Bisoprolol Are Comparable with Carvedilol in Secondary Prevention of Acute Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention
por: Jun, Seung Jin, et al.
Publicado: (2018)

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction
por: Frishman, William H, et al.
Publicado: (2008)

Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study
por: Falskov, Britt, et al.
Publicado: (2011)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures
por: Vinik, Aaron I., et al.
Publicado: (2014)

A comparison of anti‐arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter‐defibrillators
por: Ayan, Mohamed, et al.
Publicado: (2019)

Nebivolol versus Carvedilol or Metoprolol in Patients Presenting with Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction
por: Ozaydin, Mehmet, et al.
Publicado: (2016)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results
por: Bloom, Heather L., et al.
Publicado: (2014)

Comparison of carvedilol versus metoprolol in patients with acute myocardial infarction: A protocol for systematic review and meta-analysis
por: Zhang, Jian-gang, et al.
Publicado: (2021)

Use of Response Surface Methodology in the Formulation and Optimization of Bisoprolol Fumarate Matrix Tablets for Sustained Drug Release
por: Malakar, Jadupati, et al.
Publicado: (2012)

Do Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis Have the Same Clinical Outcomes? A Ten-year Cohort Study in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2016)

Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study
por: Kveiborg, Britt, et al.
Publicado: (2010)

Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial
por: Choi, Dong-Ju, et al.
Publicado: (2018)

Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway
por: Wang, Min, et al.
Publicado: (2020)

Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway
por: Wang, Min, et al.
Publicado: (2022)

Comparative Study of Selected Excipients’ Influence on Carvedilol Release from Hypromellose Matrix Tablets
por: Ojsteršek, Tadej, et al.
Publicado: (2023)

Correction: Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial
por: Choi, Dong-Ju, et al.
Publicado: (2022)

Dose proportionality and pharmacokinetics of carvedilol sustained-release formulation: a single dose-ascending 10-sequence incomplete block study
por: Kim, Yo Han, et al.
Publicado: (2015)

Influence of Formulation Factors and Compression Force on Release Profile of Sustained Release Metoprolol Tablets using Compritol(®) 888ATO as Lipid Excipient
por: Patere, Shilpa N., et al.
Publicado: (2015)

Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release
por: Roesch, Benno, et al.
Publicado: (2013)

Economic costs of automated and continuous ambulatory peritoneal dialysis in Taiwan: a combined survey and retrospective cohort analysis
por: Tang, Chao-Hsiun, et al.
Publicado: (2017)

Out-of-pocket costs and productivity losses in haemodialysis and peritoneal dialysis from a patient interview survey in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2019)

Comparing the Therapeutic Effects of Carvedilol and Metoprolol on Prevention of Atrial Fibrillation after Coronary Artery Bypass Surgery, a Double-Blind Study
por: Jalalian, Rozita, et al.
Publicado: (2014)

Optimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbits
por: El-Say, Khalid Mohamed, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tssdng1spv52q48rva5hkne1po